Protagen AG appoints Bernhard Kirschbaum as new Board Member
8 January 2015 | By PROTAGEN AG
PROTAGEN AG, a leading specialist in the development of novel diagnostic tests and companion diagnostics (CDx) in the autoimmune field, announced that the former Head of Research and Early Development of Merck Serono, Dr. Bernhard Kirschbaum, has joined the company’s Supervisory Board...